期刊文献+

CEA、CA19-9在胆石症患者中的检测意义 被引量:4

Detective significance of CEA,CA19-9 in patients with cholelithiasis
暂未订购
导出
摘要 目的探析胆石症患者血清癌胚抗原(CEA)以及糖类抗原19-9(CA19-9)表达的临床价值。方法分析2011年2月至2015年2月在我院接受治疗的98例胆石症患者(根据术前血清CEA、CA19-9的表达水平分为正常组52例和上升组46例)和44例腹股沟疝患者(对照组)的临床资料。检测受试者血清CEA、CA19-9及炎症因子的表达水平并进行比较,分析其在治疗胆石症患者中的重要作用。结果正常组与对照组间CEA、CA19-9及炎症因子的比较无统计学差异(P>0.05),而上升组患者的CEA、CA19-9及炎症因子均高于对照组,且差异具有统计学意义(P<0.05);术后与术前相比,正常组CEA、CA19-9及炎症因子的表达水平无统计学差异(P>0.05),而上升组的患者则明显降低,差异具有统计学意义(P<0.05)。结论胆石症患者中血清CEA、CA19-9的表达水平与胆道炎症有着一定的联系,胆道炎症较为严重时患者血清CEA、CA19-9表达水平上升。 Objective Our retrospective study was aimed to analyze the clinical value of serum CEA and CA19-9 in patients with cholelithiasis. Methods The clinical data of 98 patients with cholelithiasis and 44 patients with inguinal hernia received treatment in our hospital from February 2011 to February 2015 were retrospectively analyzed. The expressive levels of CEA and CA19-9 of the patients were detected and compared. The important roles of CEA and CA19-9 in the patients with cholelithiasis were analyzed. Results The levels of CEA,CA19-9and inflammatory factors in normal group and control group had no statistical differences( P〈0. 05). The levels of CEA,CA19-9 and inflammatory factors in rising group were higher than those in control group( P〉0. 05). The levels of CEA,CA19-9,inflammatory factors before and after the treatment had no statistical differences( P〉0. 05),but the levels of CEA,CA19-9,inflammatory factors in rising group were obviously decreased( P〈0. 05). Conclusion The levels of CEA and CA19-9 in patients with cholelithiasis had correlation with inflammation of biliary tract,which will increased by severe choleithiasis.
机构地区 北京市海淀医院
出处 《局解手术学杂志》 2016年第4期283-285,共3页 Journal of Regional Anatomy and Operative Surgery
关键词 癌胚抗原 糖类抗原19-9 胆石症 carcinoembryonic antigen carbohydrate antigen 19-9 cholelithiasis
  • 相关文献

参考文献13

  • 1Brown LM, Rogers S J, Cello JP, et al. Cost-effective treatment of patients with symptomatic eholelithiasis and possible common bile duet stones[ J ]. J Am Coll Surg,2011,212(6) : 1049 - 1060. doi: 10. 1016/j. jameoll- surg. 2011.02. 017.
  • 2Chen CH, Yang CC, Yeh YH. For biliary dilatation, a negative en- dosonography needs additional image studies in weight loss suggesting malignancy[J]. Dig Dis Sci,2013,58 (8) :2345 -2352. doi: 10. 1007/ s10620 - 013 - 2649 - 2.
  • 3Distler M,Pilarsky E, Kersting S, et al. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal ade- noearcinoma of the pancreas-a retrospective tumor marker prognostie study[ J]. Int Surg,2013,11 (10) :1067 - 1072. doi:lO. 1016/j. ijsu. 2013.10. 005.
  • 4Lin MS, Huang JX, Yu H. Elevated serum level of carbohydrate antigen 19-9 in benign biliary stricture diseases can reduce its value as a tumor marker [ J ]. Int J Clin Exp Meal ,2014,7 ( 3 ) :744 - 750.
  • 5Das A, Batik S, Banerjee S, et al. A monoclonal antibody against neem leaf glycoprotein recognizes earcinoembryonie antigen (CEA) and re- stricts CEA expressing tumor growth [ J ]. J Immunother, 2014,37 (8) : 394 - 406. doi : 10. 1097/CJI.
  • 6刘羽,焦志凯,李勇,范立侨,赵群,郝英杰,檀碧波.胃癌血清及骨髓中CA72-4、MG7-Ag、CEA联合检测的意义[J].中国老年学杂志,2012,32(3):481-482. 被引量:8
  • 7吴伟,王少峰.血清CA19-9检测对胆胰疾病的诊断价值[J].中国现代医药杂志,2012,14(6):4-6. 被引量:7
  • 8Abe M, Matsuura T, Hyoki M, et al. Examination of the patient serum presenting a CEA false high value after cancer immuno-cell therapy[ J]. Rinsho Byori,2011,59(8) :763 -769.
  • 9秦兴雷,李志强,石景森,张练,王作仁,王林.血清和胆汁CA19-9联合检测对诊断胆道良恶性病变的价值[J].中国普外基础与临床杂志,2000,7(3):161-163. 被引量:38
  • 10Lumachi F, Lo RG,Tozzoli R, et al. Measurement of serum carcinoem- bryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a prelimi- nary case-control study [ J ]. Anticancer Res, 2014,34 ( 11 ) : 6663 - 6667.

二级参考文献31

  • 1陈建明,何穗,龙国文,樊斌.良性胆道疾病CA19-9检测的临床意义[J].中国医疗前沿,2008,3(13):91-92. 被引量:4
  • 2Bain GH,Petty RD.Predicting response to treatment in gastroesophagealjunction adenocarcinomas:combining clinical,imaging,and molecular bio-markers[J].Oncologist,2010;15(3):270-84.
  • 3Cappellani A,Zanghi A,Di Vita M,et al.Clinical and biological markersin gastric cancer:update and perspectives[J].Front Biosci,2010;2:403-12.
  • 4Chen Z,Hong L,Liu L,et al.Monoclonal antibody MG7 as a screeningtool for gastric cancer[J].Hybridoma,2010;29(1):27-30.
  • 5Kumar Y,Tapuria N,Kirmani N,et al.Tumour M2-pyruvate kinase:a gas-trointestinal cancer marker[J].Eur J Gastroenterol Hepatol,2007;19(3):265-76.
  • 6Hoglund C, RobertsPJ, Kuusela P, et al . Evaluati on of CA19-9 as an serum tumor marker in pancreatic cancer〔J〕. Br J Cancer, 1986; 53(2)∶197
  • 7陆雪龙 王百正 时红珍.CA19—9RIA的临床观察〔J〕[J].放射免疫学杂志,1992,5(4):222-222.
  • 8秦兴雷 石景森 王作仁等.血清和胆汁CA19—9、CEA联合检测在胆道疾病中的对比研究〔J〕[J].中华实验外科杂志,1997,:28-28.
  • 9Ohshio G, Manabe T, Watanable Y, et al. Comparative studies of DU-PAN-2,carcinoembryonic antigen, and CA19-9 in the serum and bile of patie nts with pancreaticand biliary tract disease: evaluation of the influence of ob structive jaundice 〔J〕.Am J Gastroenterol, 1990; 85(10)∶1370
  • 10Albert MB, Steinberg WM, Henry JP. Elevated serum levels of tumor m arker CA19-9 inacute cholangitis 〔J〕. Dig Dis Sci, 1988; 33(10)∶1223

共引文献74

同被引文献58

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部